Skip to main content
. Author manuscript; available in PMC: 2019 Nov 5.
Published in final edited form as: Mol Pharm. 2018 Oct 1;15(11):4814–4826. doi: 10.1021/acs.molpharmaceut.8b00434

Figure 7.

Figure 7.

Loading efficiency of mPEG–OC/DNA and mPEG–C/DNA nanocomplexes. (a) Naked DNA, lane 1: ladder, lane 2: naked DNA without nebulization, lane 3: naked DNA with nebulization; (b) mPEG–OC/DNA nanocomplexes without nebulization; (c) mPEG–C/DNA nanocomplexes without nebulization; (d) mPEG–OC/DNA nanocomplexes after nebulization; (e) mPEG–C nanocomplexes after nebulization. In (b–e), lane 1: ladder, lane 2: naked DNA without nebulization, lanes 3–9: nanocomplexes at N/P ratios of 0.5, 1, 2, 5, 10, 20, and 30, respectively.